Access cutting-edge chronic myelogenous leukemia treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access chronic myelogenous leukemia specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myelogenous leukemia treatment provided free
This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this chronic myelogenous leukemia clinical trial in Portland, OR
If you're searching for chronic myelogenous leukemia treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myelogenous leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.